Injection Practices in the Developing World - Results and Recommendations from Field Studies in Uganda and Indonesia - EDM Research Series No. 020
(1996; 157 pages) Voir le document au format PDF
Table des matières
Afficher le documentExecutive summary
Afficher le documentAcknowledgements
Ouvrir ce répertoire et afficher son contenu1. Introduction
Ouvrir ce répertoire et afficher son contenu2. Towards a rapid assessment methodology for injection practices research
Ouvrir ce répertoire et afficher son contenu3. Background: the social and cultural context of injections
Fermer ce répertoire4. The prevalence of injection use in Uganda and Indonesia
Afficher le document4.1 Health care context in Uganda and Indonesia
Afficher le document4.2 Prevalence of injection use at the household level
Afficher le document4.3 Illness-related injection use at the household level
Afficher le document4.4 Type of injections
Afficher le document4.5 Injection use by age and sex
Afficher le document4.6 Source of injections
Afficher le document4.7 Injection rates at health facilities
Afficher le document4.8 The distribution channels of injections
Afficher le document4.9 Conclusion
Ouvrir ce répertoire et afficher son contenu5. The popularity of injections in Uganda and Indonesia
Ouvrir ce répertoire et afficher son contenu6. The appropriateness of injection use in Uganda and Indonesia
Ouvrir ce répertoire et afficher son contenu7. Conclusions and recommendations
Afficher le documentReferences
Ouvrir ce répertoire et afficher son contenuAppendix 1: Indicators for injection use and for assessment of hygienic practices
Ouvrir ce répertoire et afficher son contenuAppendix 2: Methods applied in the injection practices research
Ouvrir ce répertoire et afficher son contenuAppendix 3: Tools used in the injection practices research
 

4. The prevalence of injection use in Uganda and Indonesia

In this chapter the data on the prevalence of injection use in Uganda and Indonesia are presented. First, a brief overview of the health care context in Uganda and Indonesia is given. More information can be found in the country reports15. The results of the study are presented following the indicators described in Chapter 2.2. When appropriate, the results of the study in Thailand (WHO/DAP/94.8) where similar indicators were used are included.

15Indonesia: Salan, R. & Murad J., 1994, Injection Practice Research in Indonesia. Jakarta: National Institute for Health Research and Development, unpublished report.

Uganda: Birungi H, Asiimwe D, Whyte SR. 1994, Injection Use and Practices in Uganda. Geneva: WHO/DAP/94.18.

For the data gathered in the household questionnaires, statistical significance tests (Chi Square) are performed when appropriate16.

16Results are called statistically significant when p=0.05. When results are highly significant, this is indicated by (*p=0.01) and (**p=0.001).

vers la section précédente
vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019